Shi et al (112) reported that proto-oncogene MYCN activates IGF2BP1, and subsequently, IGF2BP1 enhances the stability of the carcinogen miR210HG and mediates its carcinogenic function in BC. Here, IGF2BP1 is linked to breast cancer.